Black Diamond Therapeutics, Inc. · NASDAQ:BDTX

BB Biotech AG reported a 15.10% stake in Black Diamond Therapeutics, Inc. (Schedule 13G/A)

Event Dec 31, 2024 · Filed Feb 14, 2025

BB Biotech AG reported a 15.10% stake in Black Diamond Therapeutics, Inc., 8,517,839 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).

Stake
15.10%
Shares
8,517,839
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
BB Biotech AG15.10%8,517,839
Biotech Growth N.V.15.10%8,517,839

Source

View original at SEC

Related